571 Exploring anti-PD-1 resistance mechanisms for therapeutic targeting in non-small cell lung cancer
Haoyi Wu(The University of Texas MD Anderson Cancer Center), Don L. Gibbons(The University of Texas MD Anderson Cancer Center), Jessica Konen(Emory University), B. Leticia Rodriguez(The University of Texas MD Anderson Cancer Center), Yanhua Tian(Chinese Academy of Medical Sciences & Peking Union Medical College), Jared J. Fradette(The University of Texas MD Anderson Cancer Center)
Cited by 1
Related Papers
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non–Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study
|Journal of Clinical Oncology|2019|1.3k
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study
|The Lancet Oncology|2016|1.1k
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression
|Genes & Development|2009|515
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion
|Nature Communications|2020|435